Lamb Peter 4

4 · EXELIXIS, INC. · Filed Nov 17, 2021

Insider Transaction Report

Form 4

Period: 2021-11-15

EXELIXIS, INC.EXEL

Lamb Peter

EVP, Scientific Strategy & CSO

Transactions

Exercise/Conversion
Common Stock
[F1]
2021-11-15$6.21/sh+47,500$294,975→ 458,740 total
Sale
Common Stock
[F2][F3]
2021-11-15$18.09/sh−47,500$859,275→ 411,240 total
Tax Payment
Common Stock
[F4]
2021-11-15$18.10/sh−6,818$123,406→ 404,422 total
Tax Payment
Common Stock
[F5]
2021-11-15$18.10/sh−2,323$42,046→ 402,099 total
Tax Payment
Common Stock
[F6]
2021-11-15$18.10/sh−53,022$959,698→ 349,077 total
Exercise/Conversion
Option (right to buy)
[F8]
2021-11-15−47,500→ 47,500 total
Exercise: $6.21From: 2016-09-16Exp: 2022-09-15→ Common Stock (47,500 underlying)

Holdings

Common Stock
[F7]
(indirect: By 401(k))
17,105

Footnotes (8)

[F1]Includes 104,202 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
[F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2021.
[F3]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.94 to $18.28. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
[F4]Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017.
[F5]Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 2, 2020.
[F6]Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on October 22, 2020.
[F7]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 12, 2021.
[F8]The option, representing the right to purchase a total of 190,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019.

Signature

/s/ Jennifer Drimmer Rokovich, Attorney in Fact|2021-11-17

Documents

1 file

4
wf-form4_163719731783522.xmlPrimary
FORM 4